Cargando…
1084. Comparative Outcomes Among Patients Receiving Varying Daptomycin Dosing Regimens in Hemodialysis
BACKGROUND: Daptomycin (DAP) has become an appealing treatment option for gram-positive infections, which are common in patients receiving hemodialysis (HD), due to frequent access and manipulation. The approved DAP dosing of 4 to 6 mg/kg every 48 hours (q48h) quickly becomes desynchronized from the...
Autores principales: | Maxwell, Tyler, Orban, James E, Kufel, Wesley D, Destache, Christopher, Williams, Karen S, Velagapudi, Manasa, Brandon Bookstaver, P, Tatem, Luis, McCracken, James A, Carpenter, Bethanne, Sharma, Roopali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644717/ http://dx.doi.org/10.1093/ofid/ofab466.1278 |
Ejemplares similares
-
1084. A Pre- and Post-Intervention Study to Implement a Successful Antimicrobial Stewardship Program at an Urban Chronic Hemodialysis Center
por: Park, Jenny, et al.
Publicado: (2019) -
1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014) -
1084. Nocardia Cyriacigeorgica Endocarditis
por: Bhayani, Nikhil, et al.
Publicado: (2018) -
1084 UNUSUAL LABORATORY FINDINGS IN ECHOVIRUS-11 MENINGITIS
por: Thompson, C Hurry, et al.
Publicado: (1981) -
Doxycycline Induced Pancreatitis: An Uncommon Complication of a Common Drug
por: Reiche, William, et al.
Publicado: (2022)